Golden Throat Holdings Group Company Limited (HKG:6896)

Hong Kong · Delayed Price · Currency is HKD

3.050

-0.040 (-1.29%)

Jun 18, 2026, 3:57 PM HKT

-31.92% (1Y)

Market Cap	2.25B -43.3%
Revenue (ttm)	1.05B -20.4%
Net Income	279.54M -21.2%
EPS	0.38 -21.2%
Shares Out	739.30M
PE Ratio	8.07
Forward PE	n/a
Dividend	0.34 (11.15%)
Ex-Dividend Date	Jun 16, 2026

Volume	490,000
Open	3.090
Previous Close	3.090
Day's Range	3.050 - 3.140
52-Week Range	3.000 - 5.150
Beta	-0.16
Analysts	Hold
Price Target	7.17 (+135.08%)
Earnings Date	Mar 27, 2026

About HKG:6896

Golden Throat Holdings Group Company Limited, an investment holding company, manufactures and sells pharmaceutical, healthcare food, and other products in the People’s Republic of China and internationally. The company offers Golden Throat Lozenges, an over-the-counter medicine to relieve symptoms of sore and dry throat, and hoarse voice caused by acute pharyngitis. It also provides Golden Throat Lozenge series products, which include Dule Lozenges; sugar-free Dule Lozenges; and other sugar free flavors, such as orange, fructus momordicae, chry... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1956

Employees 840

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 6896

Full Company Profile

Financial Performance

In 2025, HKG:6896's revenue was 943.26 million, a decrease of -20.40% compared to the previous year's 1.19 billion. Earnings were 251.20 million, a decrease of -21.16%.

Financial numbers in CNY Financial Statements